High-throughput screen for small molecule inhibitors of DNA mismatch repair


Year:

Session type:

Nicholas Pedley, Cecilia Lundin, Daniel Ebner, Thomas Helleday

University of Oxford, UK

Abstract

The exploitation of tumour genetic abnormalities through the drugging of synthetic lethal targets is central to the work of our laboratory.